CDC consulation with stakeholders

Question

8. What safeguards will be in place to ensure the CDC operates independently of pharmaceutical industry influence? 9. Will the CDC publicly disclose all funding sources, advisory relationships and potential conflicts of interest relating to senior staff, advisory committees and expert panels? 10. How will the CDC ensure that a diversity of scientific and clinical perspectives is considered in policy development, particularly during rapidly evolving public health emergencies? 14. How will the CDC engage with healthcare professionals who hold differing clinical or scientific views while maintaining appropriate professional and regulatory standards? 16. The CDC has stated that it will exchange data with a range of entities. What principles will guide the CDC's approach to digital health tools, data collection, data sharing and privacy protection? 17. How will individual medical privacy be safeguarded in the operation of large-scale health data systems? 20. Does Australia participate in or fund directly or indirectly any gain of function research?

Answer

Please see attached answer.

Documents

• Question with answer (PDF) (opens in a new tab)
• ACDC SQ26-002839.pdf (opens in a new tab)